avail 0 ToS
Gribbly Flu: The World’s Worry and Europe’s Response
The avian flu H5N1, long a source of medical concern, has now grown into a global threat. With cases reported worldwide, this strain is no longer just a bird matter, but a human concern too. Unfortunately, the alarming tally isn’t slowing down; last week, Louisiana, USA, reported its first human death from the virus.
Western nations have been proactive, stockpiling vaccines for their citizens. The USA was the first to acquire these, followed by the UK and the EU, which together purchased 665,000 doses in June. Spain, initially neutral, has now joined the ranks. A Ministry spokesperson confirmed to El País that Spain will participate in the next EU joint purchase.
These vaccines, manufactured by CSL Seqirus, are primarily for professionals working with farm animals and veterinarians. They’re effective for six months and older, requiring two doses each.
But why the sudden change of heart? Mutations of the virus may hold the answer. Cases are rising, with humans contracting the virus through contacts with infected poultry or through contaminated products. Canada and the US have reported severe cases, including the first human fatality—a 65-year-old man with respiratory issues who contacted infected birds.
Worryingly, genetic analyses reveal mutations in both the US and Canada cases not present in the bird strains, suggesting enhanced human infectivity. The World Health Organization (WHO) acknowledges the risk but maintains it’s low—so far, there’s no evidence of human-to-human transmission. However, experts warn that such mutations could signal the beginning of a potential pandemic.
Since 2021, the US has recorded 66 human cases, mostly in agriculture workers. Despite these numbers, WHO believes the world is ill-prepared to contain outbreaks like these. Marion Koopmans, a Dutch virologist, echoes this concern, "This is how pandemics start."
Worth a look